Free Trial

Denali Therapeutics (DNLI) News Today

Denali Therapeutics logo
$13.54 +0.50 (+3.83%)
Closing price 04:00 PM Eastern
Extended Trading
$13.69 +0.15 (+1.10%)
As of 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DNLI Latest News

Denali Therapeutics Inc. stock logo
Bank of America Corp DE Trims Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Bank of America Corp DE lessened its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 22.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 270,333 shares of the company's stock after selling 77,831 sh
Denali Therapeutics Inc. stock logo
Polar Asset Management Partners Inc. Increases Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
Polar Asset Management Partners Inc. increased its stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 1,240.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 551,09
Denali Therapeutics Inc. stock logo
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 4.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,582,
Denali Therapeutics Inc. stock logo
Woodline Partners LP Makes New $2.04 Million Investment in Denali Therapeutics Inc. (NASDAQ:DNLI)
Woodline Partners LP bought a new position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 100,000 shares of the company's stock, valued at approximately $2,038,000. Woodline Par
Denali Therapeutics Inc. stock logo
Millennium Management LLC Acquires 344,056 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Millennium Management LLC grew its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 571.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 404,224 shares of the company's stock after purchasing an ad
Denali Therapeutics Inc. stock logo
Twinbeech Capital LP Invests $5.19 Million in Denali Therapeutics Inc. (NASDAQ:DNLI)
Twinbeech Capital LP purchased a new position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 254,586 shares of the company's stock, valued
Denali Therapeutics Inc. stock logo
Rafferty Asset Management LLC Buys 23,629 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Rafferty Asset Management LLC increased its stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 20.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 141,310 shares of the company's stock a
Denali Therapeutics Inc. stock logo
Point72 Asset Management L.P. Has $11.18 Million Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Point72 Asset Management L.P. grew its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 64.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 548,739 shares of the company's stock afte
Denali Therapeutics Inc. stock logo
Deutsche Bank AG Buys 37,907 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Deutsche Bank AG increased its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 15.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 277,853 shares of the company's stock after buying an additional 37,907 shares during the period.
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Acquired by Polar Asset Management Partners Inc.
Polar Asset Management Partners Inc. raised its stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 1,240.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 551,092 shares of the company's stock after purchasing an additional 509,992 shares during t
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Average Recommendation of "Buy" from Analysts
Denali Therapeutics Inc. (NASDAQ:DNLI - Get Free Report) has earned an average recommendation of "Buy" from the seventeen analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and two have giv
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Bought by Northern Trust Corp
Northern Trust Corp grew its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 10.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,201,518 shares of the company's stock after acqui
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Sold by Jane Street Group LLC
Jane Street Group LLC lowered its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 37.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 229,165 shares of the company's stock after sel
Denali Therapeutics Inc. stock logo
Q3 EPS Estimate for Denali Therapeutics Lowered by Analyst
Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) - Leerink Partnrs decreased their Q3 2025 earnings estimates for shares of Denali Therapeutics in a report issued on Wednesday, May 7th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings per share of ($0.68) for
Denali Therapeutics Inc. stock logo
B. Riley Forecasts Lower Earnings for Denali Therapeutics
Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) - Equities researchers at B. Riley lowered their Q2 2025 earnings per share (EPS) estimates for shares of Denali Therapeutics in a research report issued on Wednesday, May 7th. B. Riley analyst M. Mamtani now expects that the company will post
Denali Therapeutics Inc. stock logo
HC Wainwright Issues Optimistic Estimate for DNLI Earnings
Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) - Equities research analysts at HC Wainwright lifted their Q2 2025 earnings estimates for Denali Therapeutics in a research note issued on Wednesday, May 7th. HC Wainwright analyst A. Fein now expects that the company will earn ($0.68) per shar
Denali Therapeutics Inc. stock logo
Q2 EPS Estimates for Denali Therapeutics Raised by Wedbush
Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) - Analysts at Wedbush upped their Q2 2025 earnings per share estimates for Denali Therapeutics in a report released on Wednesday, May 7th. Wedbush analyst L. Chico now expects that the company will earn ($0.76) per share for the quarter, up fro
Denali Therapeutics Inc. stock logo
Fred Alger Management LLC Sells 29,509 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Fred Alger Management LLC lowered its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 24.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 91,807 shares of the company's stock after selling
Denali Therapeutics Inc. stock logo
Balyasny Asset Management L.P. Grows Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)
Balyasny Asset Management L.P. boosted its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 822.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 416,074 shares of the company's stock after buying an additional 370,966 s
Denali Therapeutics Inc. stock logo
Raymond James Financial Inc. Invests $533,000 in Denali Therapeutics Inc. (NASDAQ:DNLI)
Raymond James Financial Inc. acquired a new stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 26,143 shares of the company's stock, valued at approximately $533,000. A num
Denali Therapeutics Inc. stock logo
Robert W. Baird Has Lowered Expectations for Denali Therapeutics (NASDAQ:DNLI) Stock Price
Robert W. Baird lowered their target price on shares of Denali Therapeutics from $30.00 to $29.00 and set an "outperform" rating on the stock in a report on Thursday.
Denali Therapeutics Inc. stock logo
HC Wainwright Cuts Denali Therapeutics (NASDAQ:DNLI) Price Target to $32.00
HC Wainwright dropped their price target on shares of Denali Therapeutics from $80.00 to $32.00 and set a "buy" rating for the company in a research note on Wednesday.
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Stock Position Decreased by Axa S.A.
Axa S.A. decreased its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 14.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 293,755 shares of the company's stock after selling 51,128 shares during the qu
Denali Therapeutics Inc. stock logo
First Trust Advisors LP Acquires 47,308 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
First Trust Advisors LP lifted its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 260.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,442 shares of the
Denali Therapeutics Inc. stock logo
Crestline Management LP Has $87.85 Million Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
Crestline Management LP decreased its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 3.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,310,732 shares of the company's st
Denali Therapeutics Inc. stock logo
Dimensional Fund Advisors LP Has $37.81 Million Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Dimensional Fund Advisors LP lifted its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 19.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,855,036 shares of the company's stock after purc
Denali Therapeutics Inc. stock logo
Aquatic Capital Management LLC Purchases Shares of 15,694 Denali Therapeutics Inc. (NASDAQ:DNLI)
Aquatic Capital Management LLC acquired a new position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 15,694 shares of the company's stock, valued at approximately $320,000. Several other hedge f
Denali Therapeutics Inc. stock logo
Denali Therapeutics (DNLI) Projected to Post Quarterly Earnings on Tuesday
Denali Therapeutics (NASDAQ:DNLI) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-denali-therapeutics-inc-stock/)
Denali Therapeutics Inc. stock logo
Susquehanna Fundamental Investments LLC Acquires New Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Susquehanna Fundamental Investments LLC bought a new position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 192,563 shares of the company's stock, valued at approximately $3,
Denali Therapeutics Inc. stock logo
Price T Rowe Associates Inc. MD Grows Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Price T Rowe Associates Inc. MD lifted its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 6.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,058,615 shares of the company's stoc
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Sold by Invesco Ltd.
Invesco Ltd. cut its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 41.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 121,478 shares of the company's stock after selling
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Upgraded to Strong-Buy at William Blair
William Blair raised Denali Therapeutics to a "strong-buy" rating in a report on Thursday.
Denali Therapeutics Inc. stock logo
Barclays PLC Has $5.67 Million Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)
Barclays PLC grew its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 8.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 278,067 shares of the company's stock after purchasing an additional 22
Denali Therapeutics Inc. stock logo
24,820 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Bought by Walleye Capital LLC
Walleye Capital LLC bought a new stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 24,820 shares of the company's stock, valued at approxi
Denali Therapeutics Inc. stock logo
Guggenheim Capital LLC Acquires 27,518 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Guggenheim Capital LLC lifted its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 133.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,131 shares of the c
Denali Therapeutics Inc. stock logo
60,000 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Bought by Diadema Partners LP
Diadema Partners LP purchased a new stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 60,000 shares of the company's stock, valued at appro
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Stock Price Up 6.6% - Time to Buy?
Denali Therapeutics (NASDAQ:DNLI) Stock Price Up 6.6% - Here's What Happened
Denali Therapeutics Inc. stock logo
Capital Research Global Investors Decreases Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
Capital Research Global Investors lowered its stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 30.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 5,477,211 shares of the company's stock after selling 2,431,903 shares during the quarter. Ca
Denali Therapeutics Inc. stock logo
Marshall Wace LLP Sells 178,404 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Marshall Wace LLP lessened its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 9.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,788,737 shares of the company's stock after selling 178,404 shares during the period. Marshall Wa
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Consensus Recommendation of "Buy" from Brokerages
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Get Free Report) have received a consensus rating of "Buy" from the seventeen research firms that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, fifteen have assigned a b
Denali Therapeutics Inc. stock logo
Fmr LLC Buys 188,368 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Fmr LLC lifted its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 2.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 8,019,746 shares of the company's stock after purchasing an additional 188,368 shares during the quarte
Denali Therapeutics Inc. stock logo
Geode Capital Management LLC Trims Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
Geode Capital Management LLC lowered its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 0.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,935,283 shares of the company's stock afte
Denali Therapeutics Inc. stock logo
Cantor Fitzgerald Analysts Lower Earnings Estimates for DNLI
Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) - Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings estimates for Denali Therapeutics in a research report issued to clients and investors on Thursday, April 10th. Cantor Fitzgerald analyst J. Schimmer now forecasts that
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Stock Rating Upgraded by Cantor Fitzgerald
Cantor Fitzgerald raised Denali Therapeutics from a "neutral" rating to an "overweight" rating in a research report on Thursday.
Denali Therapeutics Inc. stock logo
Trexquant Investment LP Buys 36,122 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Trexquant Investment LP increased its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 147.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 60,656 shares of the company's stock after p
Get Denali Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DNLI and its competitors with MarketBeat's FREE daily newsletter.

DNLI Media Mentions By Week

DNLI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DNLI
News Sentiment

1.74

0.88

Average
Medical
News Sentiment

DNLI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DNLI Articles
This Week

7

6

DNLI Articles
Average Week

Get Denali Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DNLI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:DNLI) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners